<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02502539</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-0234</org_study_id>
    <secondary_id>2015-A00607-42</secondary_id>
    <nct_id>NCT02502539</nct_id>
  </id_info>
  <brief_title>Cellular and Molecular Adaptations to Exercise-induced Inflammatory Response in Children With Autoimmune Diseases</brief_title>
  <acronym>AJI-APA</acronym>
  <official_title>Cellular and Molecular Adaptations to Exercise-induced Inflammatory Response in Children With Autoimmune Diseases</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <brief_summary>
    <textblock>
      Juvenile idiopathic arthritis (JIA) is a chronic disease characterized by persistent joint
      inflammation. The immune system disruption that leads to overproduction of pro-inflammatory
      cytokines (TNF-α, IL-1, IL-6) is a cascade of events on different levels—some molecular, some
      cellular, and some systemic. Our objective is to identify the mechanisms through which
      physical activity is liable to mediate inflammatory balance in autoimmune disease settings,
      and specifically in JIA patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Feasibility study
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>July 2015</start_date>
  <completion_date type="Anticipated">January 2017</completion_date>
  <primary_completion_date type="Anticipated">October 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percent change</measure>
    <time_frame>AT DAY 1</time_frame>
    <description>Percent change, before and after a controlled session of physical activity session, of serum and secretion kinetics of IL-6 and its soluble receptors (sIL- 6R and sgp130)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain (VAS)</measure>
    <time_frame>at day 1</time_frame>
    <description>to assess slipping quality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>locomotors function (CHAQ)</measure>
    <time_frame>at day 1</time_frame>
    <description>to assess slipping quality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>swelling of knee</measure>
    <time_frame>at day 1</time_frame>
    <description>to assess slipping quality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>rate of miRNA</measure>
    <time_frame>at day 1</time_frame>
    <description>to assess slipping quality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>plasma level of melatonin</measure>
    <time_frame>at day 1</time_frame>
    <description>to assess slipping quality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sitfness of knee</measure>
    <time_frame>at day 1</time_frame>
    <description>to assess slipping quality</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Juvenile Idiopathic Arthritis</condition>
  <arm_group>
    <arm_group_label>autoimmune disease</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>to identify the mechanisms through which physical activity is liable to mediate inflammatory balance in autoimmune disease settings, and specifically in JIA patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Controlled physical activity</intervention_name>
    <arm_group_label>autoimmune disease</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children between 8 and 12 years

          -  Tanner stage &lt; T2

          -  polyarthritis, oligoarthritis and ERA sub-type of JIA

          -  Stable disease during 3 months before starting study

        Exclusion Criteria:

          -  Infection

          -  Fever

          -  Anti-IL6 treatment

          -  More than 6h per week of physical activity

          -  Systemic corticosteroid treatment during the 3 months before starting study

          -  Systemic JIA

          -  JIA not mastered by treatments

          -  Other autoimmunity or auto-inflammatory diseases

          -  Participation in another clinical research protocol
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>8 Years</minimum_age>
    <maximum_age>12 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Etienne MERLIN</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU ESTAING</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick LACARIN</last_name>
    <phone>04 73 75 11 95</phone>
    <email>placarin@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick LACARIN</last_name>
      <phone>04 73 75 11 95</phone>
      <email>placarin@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>Etienne MERLIN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 29, 2015</study_first_submitted>
  <study_first_submitted_qc>July 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 20, 2015</study_first_posted>
  <last_update_submitted>July 25, 2016</last_update_submitted>
  <last_update_submitted_qc>July 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Juvenile idiopathic arthritis</keyword>
  <keyword>Physical exercise</keyword>
  <keyword>Pro-anti-inflammatory balance</keyword>
  <keyword>Interleukins</keyword>
  <keyword>miRNA</keyword>
  <keyword>Calgranulins</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Autoimmune Diseases</mesh_term>
    <mesh_term>Arthritis, Juvenile</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

